Amgen Impairment of Intangible Assets decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $800.00M to $0.00. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase signals potential issues with past acquisitions or declining market value of specific product lines.
Represents a non-cash charge taken when the carrying value of an intangible asset exceeds its fair value. This indicates...
Occurs across all industries; peers may report these periodically following large-scale acquisitions.
amgn_impairment_of_intangible_assets| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $212.75M | $212.75M | $212.75M | $212.75M | $68.00M | $0.00 | $61.00M | $30.00M | $800.00M | $400.00M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -68.0% | -100.0% | — | -50.8% | >999% | -50.0% | -100.0% |
| YoY Change | — | — | — | — | -68.0% | -100.0% | -71.3% | -85.9% | >999% | +555.7% | -100.0% |